Zhujiang Hospital

This trial tests whether a single dose of mesenchymal stem cell-derived exosomes, added to dialysis fluid and infused into the abdomen, is safe and tolerable for adults with peritoneal dialysis-related dysfunction. Researchers will give increasing doses to small groups and monito…

This early-phase trial tests a single injection of PID23, a gene therapy that instructs a patient's own immune cells to attack leukemia cells. It targets three markers (CD19, BCMA, and CD70) on cancer cells. The study enrolls up to 18 people aged 3 to 75 with relapsed or refracto…

This study looks at people with advanced mouth or throat cancer who had chemotherapy and immunotherapy before surgery. After surgery, they will either get radiation, immunotherapy maintenance, or just be watched. The goal is to see which approach helps them live longer without th…

This early-phase trial tests a new type of CAR-T cell therapy (with a protein called TLR2) in 60 adults newly diagnosed with B-cell acute lymphoblastic leukemia or lymphoma who cannot tolerate intensive chemotherapy. Participants receive a single infusion of these engineered immu…

This early study tests whether nasal drops containing tiny particles from umbilical cord stem cells are safe for people who had an ischemic stroke. Nine patients will receive the drops four times over two weeks, alongside standard care. The main goal is to check for serious side …

This phase 2 trial tests whether romiplostim N01 can safely raise low platelet counts in 60 adults with solid tumors who have had radiotherapy combined with other treatments. The main goal is to see if platelet counts increase by at least 50 billion per liter within two weeks. Th…

This study tests whether a blood protein called neprilysin can predict if ICU patients with an infection will develop sepsis within 48 hours. Researchers will measure neprilysin and other biomarkers in blood samples from 488 adults at two hospitals. They will also check microcirc…

This study tests whether combining two types of brain stimulation—tDCS and rTMS—can improve motor function in people with locked-in syndrome, a condition where the body is paralyzed but the mind is awake. Researchers will enroll 72 participants and randomly assign them to receive…

This 5-year study will follow 2,800 overweight or obese Chinese adults aged 18-60 to see how their health changes over time. Participants will use a smartphone app to track their data and get lifestyle support. The goal is to understand who develops diabetes or complications, and…

This study looks at how changes in gut bacteria, driven by a substance called lactate, might be linked to the worsening of liver cirrhosis. Researchers will follow 200 people, including healthy volunteers and cirrhosis patients, to measure lactate levels in blood, stool, and tiss…

This study will examine whether a specific gut bacterium, Ruminococcus gnavus, and the chemicals it produces are linked to metabolic dysfunction-associated fatty liver disease (MAFLD). Researchers will compare 200 healthy adults and those with MAFLD to understand the connection. …